Alcohol-associated rapid release of a long-acting opioid
S Murray, E Wooltorton - Cmaj, 2005 - Can Med Assoc
Reason for posting: Palladone XL (hydromorphone hydrochloride) is a long-acting opioid for
chronic pain relief in patients with persistent, moderate-to-severe pain. A recent …
chronic pain relief in patients with persistent, moderate-to-severe pain. A recent …
Hydromorphone: evolving to meet the challenges of today's health care environment
TB Gregory - Clinical therapeutics, 2013 - Elsevier
Background Hydromorphone, a potent analogue of morphine, has long had an important
role in pain management and is included in several international guidelines for managing …
role in pain management and is included in several international guidelines for managing …
[HTML][HTML] Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsules
F Johnson, G Wagner, S Sun, J Stauffer - The Journal of Pain, 2008 - Elsevier
The recent withdrawal of hydromorphone hydrochloride extended-release capsules
(Palladone; Purdue Pharma LP, Stamford, CT) from the market after pharmacokinetic data …
(Palladone; Purdue Pharma LP, Stamford, CT) from the market after pharmacokinetic data …
Oral hydromorphone extended-release
D Guay - The Consultant Pharmacist®, 2010 - ingentaconnect.com
Objective: To review the chemistry, pharmacodynamics, pharmacokinetics, efficacy,
tolerability, dosing, and role of the Osmotic-controlled Release Oral delivery System (OROS) …
tolerability, dosing, and role of the Osmotic-controlled Release Oral delivery System (OROS) …
Extended-release hydrocodone–gift or curse?
D Krashin, N Murinova, AM Trescot - Journal of Pain Research, 2013 - Taylor & Francis
Hydrocodone is a semisynthetic opioid, which has been used for decades as a short-acting
analgesic combined with acetaminophen (or less commonly ibuprofen). Several long-acting …
analgesic combined with acetaminophen (or less commonly ibuprofen). Several long-acting …
Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone
MJ Shram, G Sathyan, S Khanna, IC Tudor… - Journal of clinical …, 2010 - journals.lww.com
Immediate release (IR) hydromorphone has experienced significant misuse and abuse. An
extended release (ER) hydromorphone formulation has been developed to provide …
extended release (ER) hydromorphone formulation has been developed to provide …
Hydromorphone use for acute pain: Misconceptions, controversies, and risks.
M Mazer-Amirshahi, S Motov… - Journal of opioid …, 2018 - europepmc.org
Hydromorphone (HM) is a potent opioid analgesic that is commonly administered in the
emergency department (ED) and other acute care settings, such as medical surgical wards …
emergency department (ED) and other acute care settings, such as medical surgical wards …
Pharmacodynamics of orally administered sustained-release hydromorphone in humans
MS Angst, DR Drover, J Lötsch… - The Journal of the …, 2001 - pubs.asahq.org
Background The disposition kinetics of hydromorphone generally necessitates oral
administration every 4 h of the conventional immediate-release tablet to provide sustained …
administration every 4 h of the conventional immediate-release tablet to provide sustained …
Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered …
SM Weinstein, M Shi, BJ Buckley, MA Kwarcinski - Clinical therapeutics, 2006 - Elsevier
BACKGROUND:: Hydromorphone hydrochloride is a μ-opioid agonist with dose-dependent
analgesic properties. Extended-release hydromorphone hydrochloride (ER hydromorphone …
analgesic properties. Extended-release hydromorphone hydrochloride (ER hydromorphone …
[PDF][PDF] Steady-state pharmacokinetics of extended-release hydromorphone (OROS hydromorphone): a randomized study in healthy volunteers
KT Moore, D St-Fleur, NC Marricco, J Ariyawansa… - J Opioid …, 2010 - researchgate.net
The steady-state pharmacokinetics of an extended-release formulation of hydromorphone,
OROS® hydromorphone, was investigated in a randomized, openlabel, crossover study in …
OROS® hydromorphone, was investigated in a randomized, openlabel, crossover study in …
Related searches
- persistent moderate hydromorphone hydrochloride
- severe pain hydromorphone hydrochloride
- severe pain persistent moderate
- open label hydromorphone hydrochloride
- prospective evaluation hydromorphone hydrochloride
- open label persistent moderate
- severe pain open label
- prospective evaluation persistent moderate
- severe pain prospective evaluation